openPR Logo
Press release

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market

"The Report PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

About Type 2 Diabetes Market

While the global T2D market is crowded with inexpensive generics and marked by a pipeline filled with me-too drugs, GlobalData expects this market to undergo substantial growth between 2016 and 2026, doubling over the forecast period. The main driver of this enormous expansion will be the dramatic increase in disease prevalence, which is attributable to increased life expectancy and an increasingly sedentary and stressful lifestyle. The second largest driver will be physicians efforts to delay disease progression and reduce the costly burden of diabetic complications through the use of combination therapies and novel branded drugs.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1350131

Despite the large number of marketed therapies, the T2D market is still experiencing large unmet needs and therefore has a significant growth opportunity for new patent-protected products. Metformin (dimethylbiguanide) will remain the first-line therapy overall for T2D due to physicians familiarity with it and the availability of long-term data, but the usage of sulfonylureas (SUs), another front-line therapy, continues to be replaced by novel therapies with improved side-effect profiles. The battle for second- or third-line therapy will involve DPP-4Is, GLP-1RAs, SGLT-Is, and other upcoming novel therapies. Of all the currently marketed classes, GLP-1RAs and SGLT-Is will experience the fastest growth due to their beneficial CV effects, weight-loss effects, and increasing ease of use.

Scope

- Overview of T2D, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
- Annualized T2D therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2016 and forecast for ten years to 2026.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the T2D therapeutics market.
- Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
- Analysis of the current and future market competition in the global T2D therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

View Report @ https://www.marketresearchreports.biz/reports/1350131/pharmapoint-type-diabetes-global-market-research-reports

Reasons to buy

The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
- Develop business strategies by understanding the trends shaping and driving the global T2D therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global T2D therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track drug sales in the global T2D therapeutics market from 2016-2026.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1350131

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 10
2 Type 2 Diabetes (T2D): Executive Summary 11
2.1 T2D Sales to Double Across 7MM 12
2.2 Multiple Opportunities Exist to Address Existing T2D Market Unmet Needs 14
2.3 The Arrival of Insulin Biosimilars and Abundance of Me-Too Drugs Illustrates Corporate Shift in Focus from Therapeutic Value Towards Competitive Pricing and Non-novel Agents that Confer Incremental Benefits 18
2.4 Glucagon-Like Peptide -1 Receptor Agonist Class Faces Intense Internal Competition, Largely Revolving Around Drugs Ability to Improve Patient Compliance/Ease of Administration and Cardiovascular Effects 19
2.5 Newest T2D Drug Class, Sodium-Glucose Cotransporter Inhibitors, Will Continue To Gain Significant Market Share Despite Concerns 19
2.6 What Do Physicians Think? 20
3 Introduction 23
3.1 Catalyst 23
3.2 Related Reports 24
4 Disease Overview 25
4.1 Etiology 25
4.2 Pathophysiology 27
4.3 Symptoms 29
4.4 Prognosis 31
4.5 Quality of Life 31
5 Epidemiology 31
5.1 Disease Background 32
5.2 Risk Factors and Comorbidities 32
5.3 Global and Historical Trends 34
5.4 Forecast Methodology 35
5.4.1 Sources Used 36
5.4.2 Forecast Assumptions and Methods 39
5.5 Epidemiological Forecast for T2D in the 8MM (2016-2026) 48
5.5.1 Diagnosed Prevalent Cases of T2D 48
5.5.2 Age-Specific Diagnosed Prevalent Cases of T2D 49
5.5.3 Sex-Specific Diagnosed Prevalent Cases of T2D 49
5.5.4 Comorbidities Among the Diagnosed Prevalent Cases of T2D 50
5.6 Discussion 54
5.6.1 Epidemiological Forecast Insight 54
5.6.2 Limitations of Analysis 55
5.6.3 Strengths of Analysis 55
6 Disease Management 57
6.1 Diagnosis and Treatment Overview 57
6.1.1 Diagnosis and Referrals 57
6.1.2 Treatment Guidelines and Leading Prescribed Drugs 58
6.1.3 Clinical Practice 63
6.2 US 64
6.3 France 66
6.4 Germany 68
6.5 Italy 71
6.6 Spain 75
6.7 UK 78
6.8 Japan 82

Buy Now @ https://www.researchmoz.com/checkout?rep_id=1350131&licType=S

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026 here

News-ID: 781277 • Views:

More Releases from MarketResearchReports.biz

Hydro-flyers Market: Moving Towards a Brighter Future
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in
Outdoor Floodlights: Technology and Market Dynamics
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume
Snow Helmets Market Future Prospects and Regional Outlook
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is

All 5 Releases


More Releases for T2D

Exclusive Forecast Study: PharmaPoint: Type 2 Diabetes - Global Drug Forecast an …
ResearchMoz presents professional and in-depth study of "PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026". This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. Summary While the global T2D market is crowded with inexpensive generics and marked by a pipeline filled with me-too drugs, GlobalData expects this market to undergo substantial growth between
Hemochromatosis-Global Drug Forecast and Market Analysis to 2026
Summary:                                      ReportsWeb.com published “Hemochromatosis-Global Drug Forecast and Market Analysis to 2026” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: While the global T2D market is crowded with inexpensive generics and marked by a pipeline filled with me-too drugs, Publisher expects this market to undergo substantial growth between 2016 and 2026, doubling over the
Epidemiology Market Analysis and Forecast to 2026-Identify the Percentage of T2D …
Market Analysis Research Report on “EpiCast Report: Type 2 Diabetes-Epidemiology Forecast to 2026” has been added to orbis research database. Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body’s inability to make use of available insulin along with relative insulin deficiency. T2D constitutes approximately 90-95% of all diabetes cases around the world, while
EpiCast Report: Type 2 Diabetes - Epidemiology Pipeline Insight and Therapeutic …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026”. Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the bodys inability to make use of available insulin along with relative insulin deficiency. Request For Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1287567 T2D
EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026
EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026 View Full Report : https://www.marketresearchreports.biz/reports/1287567/epicast-report-type-2-diabetes-epidemiology-forecast-to-2026-market-research-reports.pdf Summary Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the bodys inability to make use of available insulin along with relative insulin deficiency. T2D constitutes approximately 90-95% of all diabetes cases around the world, while type 1 diabetes and gestational diabetes
Type 2 Diabetes - Epidemiology Forecast To 2025
Summary Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the bodys inability to make use of available insulin along with relative insulin deficiency. T2D constitutes approximately 90% of all diabetes cases around the world; type 1 diabetes (T1D) and gestational diabetes make up the remaining 10% of the cases. Risk factors for T2D are